Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
57,417,494
-
Total 13F shares
-
49,305,339
-
Share change
-
-2,551,089
-
Total reported value
-
$1,615,805,180
-
Put/Call ratio
-
37%
-
Price per share
-
$32.77
-
Number of holders
-
200
-
Value change
-
-$87,146,053
-
Number of buys
-
111
-
Number of sells
-
94
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) as of Q3 2023
As of 30 Sep 2023,
Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,305,339 shares.
The largest 10 holders included
Valor Management LLC, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, Vivo Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, venBio Partners LLC, PERCEPTIVE ADVISORS LLC, and MACQUARIE GROUP LTD.
This page lists
202
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.